rxstat › Shortages › Imatinib

Imatinib shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Imatinib is in a widespread shortage in Canada. 7 of 14 reported products are affected. The latest manufacturer estimate for full recovery is Jul 31, 2026.
Products affected
7 / 14
In shortage since
Nov 14, 2021
Est. full return
Jul 31, 2026
Reports on file
42
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-IMATINIB
400MG · TABLET · APOTEX INC
DIN 02355345 · since Jun 30, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP IMATINIB
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02495066 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP IMATINIB
400MG · TABLET · JAMP PHARMA CORPORATION
DIN 02495074 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-IMATINIB
100MG · TABLET · ACCORD HEALTHCARE INC
DIN 02490986 · since Mar 22, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-IMATINIB
400MG · TABLET · ACCORD HEALTHCARE INC
DIN 02490994 · since Mar 22, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
PMS-IMATINIB
400MG · TABLET · PHARMASCIENCE INC
DIN 02431122 · since Nov 14, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-IMATINIB
100MG · TABLET · PHARMASCIENCE INC
DIN 02431114 · since Nov 14, 2021, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-IMATINIB
400MG · TABLET · APOTEX INC
DIN 02355345 · ended Mar 5, 2026 · Disruption of the manufacture of the drug.
Resolved
IMATINIB
100MG · TABLET · SANIS HEALTH INC
DIN 02504596 · ended Nov 3, 2025 · Disruption of the manufacture of the drug.
Resolved
IMATINIB
400MG · TABLET · SANIS HEALTH INC
DIN 02504618 · ended Nov 3, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP IMATINIB
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02495066 · ended Jul 31, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP IMATINIB
400MG · TABLET · JAMP PHARMA CORPORATION
DIN 02495074 · ended Jul 31, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 42 reports. All reports are on file with Health Canada.

What's happening

Imatinib is currently affected by 7 active shortage reports filed with Health Canada by APOTEX INC, JAMP PHARMA CORPORATION, ACCORD HEALTHCARE INC, PHARMASCIENCE INC.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Imatinib be back in stock in Canada?

The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Imatinib in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Partial shortageDasatinib1 of 14 reported products affectedPartial shortageEverolimus1 of 11 reported products affected · est. return Jul 10, 2026Partial shortageGefitinib1 of 4 reported products affected · est. return Dec 31, 2026Partial shortageSunitinib1 of 9 reported products affected · est. return Jul 15, 2026Shortage anticipatedAfatinib0 of 4 reported products affectedNo current shortageCapmatinib

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.